Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
aids-related opportunistic infections
MeSH D017088 - aids-related opportunistic infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009894:
Opportunistic infections
0 Companies
0 Drugs
Success rate
D015658:
Hiv infections
44 Companies
40 Drugs
$
Success rate
D017088:
Aids-related opportunistic infections
116 Companies
23 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
94
%
16/17
Approved:
15
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Dapsone
Almirall
Dapsone
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use